Speak to an expert! Call us on
0808 189 0360

Currently Regulated Clinical Trials

The future uses of cord blood are not completely known. There is a lot of promising research being conducted, but the confirmed treatments using cord blood are here. Any cord blood bank that claims to understand fully the future uses of stem cells is not being honest.

Stem cells can regenerate a heart after a heart attack


1. The treatment A potential treatment for heart failure relies on stem cells to renew the heart’s pumping tissue.
2. Cellular injection The stem cells are injected via a catheter into the heart either immediately following a heart attack or once the heart has become too weak and stiff to pump properly.
3. New life Results suggest that the stem cells can heal damaged tissues, but it is not yet clear whether the stem cells turn into adult heart cells themselves or encourage division and regeneration among existing heart cells.

March 18, 2011 — Stem cell researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue, and improved function to injured heart areas. The findings, from a small trial conducted at the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine, are published in the March 17 issue of Circulation Research: Journal of the American Heart Association.??“While this research is in the early stages,” says Joshua M. Hare, the study’s senior author and director of the Interdisciplinary Stem Cell Institute, “the findings are promising for the more than five million Americans who have enlarged hearts due to damage sustained from heart attacks.” These patients can suffer premature death, have major disability, and experience frequent hospitalizations. Options for treatment are limited to lifelong medications and major medical interventions, such as heart transplantation.

October 12, 2010: Researchers announced Monday that they had injected stem cells into a patient with a spinal cord injury on Friday, kicking off the world’s first clinical trial of a therapy derived from human embryonic stem cells.

The patient was treated at Shepherd Center, a spinal cord and brain injury center in Atlanta.

Though the trial, run by Geron Corp. of Menlo Park, Calif., is in its earliest stages — aimed primarily at testing the treatment for safety — the event stands as a landmark one for embryonic stem cell researchers, who for years have studied the cells’ potential to treat spinal cord injuries, diabetes and a variety of neurodegenerative diseases.

July 2009 : The Harvard Stem Cell Institute (HSCI) began working with Amy and E.W. Steptoe, local sibling filmmakers, who were in search of the next interesting topic for a documentary. Together we decided to tell the story of the effect that stem cell research is having now on the lives of leukemia patients and the challenges that lie ahead, both in fighting leukemia and in advancing stem cell research. This documentary is available here and was produced with the valuable input of HSCI Faculty members Scott Armstrong, MD, PhD.

News

22.02.2011
Researchers Study Cord Blood Stem Cells For Pediatric Traumatic Brain Injury

The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children.

30.11.2010
New England Cord Blood Bank Reports Increased Use Of Banked Stem Cells

New England Cord Blood Bank, Inc. (NECBB), a global cord blood processing and storage facility, announced today that the company has seen a consistent and robust increase in the cord blood units being used for transplants within the past few years.

30.11.2010
Arthritis May Be Treated With Umbilical Cord Cells

Umbilical cord stem cells may be useful in the treatment of rheumatoid arthritis (RA). Animal and in vitro experiments, described in BioMed Central’s open access journal Arthritis Research and Therapy, have shown that mesenchymal stem cells (MSCs) taken from umbilical cord blood can suppress inflammation and attenuate collagen-induced arthritis.

26.01.2010
Delivering Stem Cells Improves Major Bone Repair In Rats

“A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.”

25.01.2010
Umbilical cord could be new source of plentiful stem cells, say Pitt researchers

“Stem cells that could one day provide therapeutic options for muscle and bone disorders can be easily harvested from the tissue of the umbilical cord…”